T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Keyphrases

• COVID-19 100%
• Antiviral Response 100%
• SARS-CoV-2 Infection 100%
• T Cell Assay 100%
• T Cell Response 50%
• Healthcare Workers 16%
• Illness 16%
• Immune Function 16%
• Response Pattern 16%
• Convalescent 16%
• Coronavirus 16%
• Exposed Population 16%
• Recent Infection 16%
• Cross-reactive Immunity 16%
• Spike Protein 16%
• ORF3 16%
• T Cell Subpopulations 16%
• Pre-existing Immunity 16%
• Multiple Antigens 16%
• Memory Response 16%
• ELISPOT 16%
• Autoreactive T Cells 16%
• Pattern Characteristic 16%
• Proliferation Response 16%
• Antigen Selection 16%
• Lactate Response 16%
• Highly Exposed Seronegative 16%

Medicine and Dentistry

• Infection 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Antivirus Agent 100%
• T Cell 100%
• T-Cell Response 50%
• Volunteer 33%
• Disease 16%
• COVID-19 16%
• Coronavirus 16%
• Ex Vivo 16%
• Lactic Acid 16%
• Cell Population 16%
• Immune Function 16%

Immunology and Microbiology

• T Cell 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Cell Assay 100%
• Spike 33%
• COVID-19 16%
• Coronavirus 16%
• Cell Population 16%
• Immunity 16%
• Immunology 16%